STAT+: BIO joins the legal fight against Medicare pilot that ties drug prices to peer countries

AI Summary

The Biotechnology Innovation Organization is joining a legal challenge to a Medicare pilot that links some drug prices to prices in peer countries. The pilot tests President Trump’s most-favored-nation drug pricing approach, though its expected impact may be limited.

The model is a test of Trump's most-favored nation approach to drug pricing, though its impact is likely to be limited.